FERMENTALG (EPA:FALG)

PRESS RELEASE

published on 05/12/2026 at 17:50, 5 months 25 days ago

Launch of a capital increase with an indicative amount of approximately EUR10 million to accelerate commercial development
Fermentalg announces a capital increase of approximately €10 million to accelerate commercial development. Major shareholder Huvepharma and institutional investors show strong support. Price per share: €0.46, 20% discount to reference price

Capital Increase Institutional Investors FERMENTALG HuvePharma Price Per Share
BRIEF

published on 05/07/2026 at 18:05, 5 months 30 days ago

FERMENTALG: Update on voting rights and shares

Share Capital Voting Rights Actions AMF FERMENTALG
BRIEF

published on 05/05/2026 at 18:05, 6 months 1 day ago

Fermentalg: Strategic diversification and new launches in Q1 2026

Revenue Commercial Launch Ωrigins™ Galdieria Blue BioSolutions
BRIEF

published on 05/05/2026 at 18:05, 6 months 1 day ago

Fermentalg's Q1 2026 Sees Record Turnover Amid Strategic Shifts

FERMENTALG Q1 2026 Results Ωrigins™ BioSolutions Fish Oil Prices
PRESS RELEASE

published on 05/05/2026 at 18:00, 6 months 1 day ago

Success of the sales diversification strategy in the first quarter of 2026 and commercial launches of the new BioSolutions
Fermentalg achieves record turnover of €3.7 million in Q1 2026, with 42% sales growth excluding aquaculture. Positive outlook with rising fish oil prices and upcoming product launches

Sales Growth Product Launches Turnover FERMENTALG Fish Oil Prices
BRIEF

published on 04/30/2026 at 18:05, 6 months 6 days ago

Fermentalg makes available the Universal Registration Document

AMF Transparency Universal Registration Document FERMENTALG Financial Report 2025
BRIEF

published on 04/07/2026 at 18:05, 6 months 29 days ago

Fermentalg: Details on voting rights and shares

Share Capital Voting Rights Actions AMF FERMENTALG
BRIEF

published on 04/02/2026 at 18:05, 7 months 4 days ago

Fermentalg: 2025 Review and 2026 Outlook

Treasury Growth FERMENTALG 2025 Results BioSolutions
BRIEF

published on 04/02/2026 at 18:05, 7 months 4 days ago

Fermentalg's 2025 Financial Results: Sales Surge and Strengthened Financials

FERMENTALG 2025 Results BioSolutions Huvepharma Loan ΩRIGINS™ & Galdieria Blue
PRESS RELEASE

published on 04/02/2026 at 18:00, 7 months 4 days ago

2025 Annual Results: Strong sales growth, expansion of the customer portfolio and BioSolutions, and strengthening of the financial structure thanks to Huvepharma
Fermentalg reports a record 2025 turnover of €13.4 million, stable operating profit, post-closing loan from Huvepharma, promising outlook with new product launches, and a target of €20 million revenue by 2026

Product Launches Revenue Target FERMENTALG 2025 Turnover Huvepharma Loan

Published on 11/06/2026 at 22:15, 6 hours 46 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 16 hours 1 minute ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 16 hours 31 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 16 hours 31 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 19 hours 1 minute ago

Mongolia Tax Audit

View all ACCESSWIRE

Published on 11/06/2026 at 20:15, 8 hours 46 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 9 hours 46 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 10 hours 1 minute ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 10 hours 29 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 11 hours 1 minute ago

ARVERNE GROUP: Number shares and voting rights

View all EQS

Published on 11/06/2026 at 18:00, 11 hours 1 minute ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 11 hours 1 minute ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 11 hours 7 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 11 hours 26 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 17 hours 56 minutes ago

voting rights

View all LES ECHOS COMFI WIRE

News